UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of Multicomponent Heterogeneous Catalysts via Admixture Screening: PdBiTe Catalysts for Aerobic Oxidative Esterification of Primary Alcohols

Journal of the American Chemical Society, 2017-02, Vol.139 (4), p.1690-1698

2017

Volltextzugriff (PDF)

Continuous Flow Aerobic Alcohol Oxidation Reactions Using a Heterogeneous Ru(OH) x /Al2O3 Catalyst

Organic process research & development, 2014-11, Vol.18 (11), p.1503-1508

2014

Volltextzugriff (PDF)

Aerobic Oxidation of Diverse Primary Alcohols to Carboxylic Acids with a Heterogeneous Pd–Bi–Te/C (PBT/C) Catalyst

Organic process research & development, 2017-09, Vol.21 (9), p.1388-1393

2017

Volltextzugriff (PDF)

Enhanced Carbon Capture through Incorporation of Surfactant Additives

Industrial & engineering chemistry research, 2016-07, Vol.55 (27), p.7456-7461

2016

Volltextzugriff (PDF)

Continuous-Flow Aerobic Oxidation of Primary Alcohols with a Copper(I)/TEMPO Catalyst

Organic process research & development, 2013-10, Vol.17 (10), p.1247-1251

2013

Volltextzugriff (PDF)

Mechanistic Insights into Aerobic Oxidative Methyl Esterification of Primary Alcohols with Heterogeneous PdBiTe Catalysts

ACS catalysis, 2018-02, Vol.8 (2), p.1038-1047

2018

Volltextzugriff (PDF)

Enhancements in mass transfer for carbon capture solvents part II: Micron-sized solid particles

International journal of greenhouse gas control, 2017-06, Vol.61, p.138-145

2017

Volltextzugriff (PDF)

Enhancements in mass transfer for carbon capture solvents part I: Homogeneous catalyst

International journal of greenhouse gas control, 2017-08, Vol.63 (C), p.249-259

2017

Volltextzugriff (PDF)

Continuous Flow Aerobic Alcohol Oxidation Reactions Using a Heterogeneous Ru(OH) x /Al 2 O 3 Catalyst

Organic process research & development, 2014-11, Vol.18 (11), p.1503-1508

2014

Volltextzugriff (PDF)

Nickel-Catalyzed Hydrocarboxylation of Terminal Unactivated Alkenes: Formation of Branched Carboxylic Acids and Competing Catalyst Deactivation from CO 2 Reduction to CO

Organometallics, 2024-07, Vol.43 (13), p.1502-1510

2024

Volltextzugriff (PDF)

Nickel-Catalyzed Hydrocarboxylation of Terminal Unactivated Alkenes: Formation of Branched Carboxylic Acids and Competing Catalyst Deactivation from CO2 Reduction to CO

Organometallics, 2024-07, Vol.43 (13), p.1502-1510

2024

Volltextzugriff (PDF)

An in-vivo Assay to Identify Compounds Protective Against Light Induced Apoptosis

Advances in experimental medicine and biology, 2008, Vol.613, p.61-67

2008

Volltextzugriff (PDF)

Noble Metal Heterogeneous Catalysts for Aerobic Alcohol Oxidation: Discovery and Mechanism

Mannel, David S

2015

Volltextzugriff (PDF)

Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)

Journal of clinical oncology, 2020-11, Vol.38 (33), p.3841-3850

2020

Volltextzugriff (PDF)

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Journal of clinical oncology, 2019-06, Vol.37 (16), p.1380-1390

2019

Volltextzugriff (PDF)

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer

Journal of clinical oncology, 2019-07, Vol.37 (21), p.1810-1818

2019

Volltextzugriff (PDF)

Clinical Gynecologic Oncology

9th edition., 2017

Volltextzugriff (PDF)

Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study

Journal of clinical oncology, 2015-04, Vol.33 (10), p.1180-1185

2015

Volltextzugriff (PDF)

DiSaia and Creasman Clinical Gynecologic Oncology

10, 2023

Volltextzugriff (PDF)

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

The New England journal of medicine, 2019-11, Vol.381 (20), p.1929-1939

2019

Volltextzugriff (PDF)

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus

Gynecologic oncology, 2007-11, Vol.107 (2), p.177-185

2007

Volltextzugriff (PDF)

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

Gynecologic oncology, 2017-06, Vol.145 (3), p.519-525

2017

Volltextzugriff (PDF)

A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic oncology, 2019-03, Vol.152 (3), p.548-553

2019

Volltextzugriff (PDF)

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

The lancet oncology, 2013-02, Vol.14 (2), p.134-140

2013

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(152)

Publikationsform

Sprache

Englisch
(242)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(61)
Humans
(57)
Oncology
(53)
Female
(52)
Obstetrics And Gynecology
(42)
Middle Aged
(39)
Aged
(35)
Gynaecology & Obstetrics
(33)
Adult
(32)
Hematology
(31)
Obstetrics & Gynecology
(28)
Aged, 80 And Over
(19)
Physical Sciences
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Ovarian Neoplasms - Drug Therapy
(17)
Neoplasm Staging
(16)
Ovarian Cancer
(16)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(14)
Hematology, Oncology And Palliative Medicine
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of Multicomponent Heterogeneous Catalysts via Admixture Screening: PdBiTe Catalysts for Aerobic Oxidative Esterification of Primary Alcohols

Continuous Flow Aerobic Alcohol Oxidation Reactions Using a Heterogeneous Ru(OH) x /Al2O3 Catalyst

Aerobic Oxidation of Diverse Primary Alcohols to Carboxylic Acids with a Heterogeneous Pd–Bi–Te/C (PBT/C) Catalyst

Enhanced Carbon Capture through Incorporation of Surfactant Additives

Continuous-Flow Aerobic Oxidation of Primary Alcohols with a Copper(I)/TEMPO Catalyst

Mechanistic Insights into Aerobic Oxidative Methyl Esterification of Primary Alcohols with Heterogeneous PdBiTe Catalysts

Enhancements in mass transfer for carbon capture solvents part II: Micron-sized solid particles

Enhancements in mass transfer for carbon capture solvents part I: Homogeneous catalyst

Continuous Flow Aerobic Alcohol Oxidation Reactions Using a Heterogeneous Ru(OH) x /Al 2 O 3 Catalyst

Nickel-Catalyzed Hydrocarboxylation of Terminal Unactivated Alkenes: Formation of Branched Carboxylic Acids and Competing Catalyst Deactivation from CO 2 Reduction to CO

Nickel-Catalyzed Hydrocarboxylation of Terminal Unactivated Alkenes: Formation of Branched Carboxylic Acids and Competing Catalyst Deactivation from CO2 Reduction to CO

An in-vivo Assay to Identify Compounds Protective Against Light Induced Apoptosis

Noble Metal Heterogeneous Catalysts for Aerobic Alcohol Oxidation: Discovery and Mechanism

Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

Clinical Gynecologic Oncology

Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study

DiSaia and Creasman Clinical Gynecologic Oncology

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

Suchergebnisse filtern